Company Filing History:
Years Active: 1996-1997
Title: Malcolm Riddell: Innovator in Monoclonal Antibody Assays
Introduction
Malcolm Riddell is a notable inventor based in Vero Beach, FL (US). He has made significant contributions to the field of biomedical technology, particularly in the development of assays for detecting metal cations in body fluids. With a total of 2 patents, Riddell's work has the potential to impact medical diagnostics significantly.
Latest Patents
Riddell's latest patent is a monoclonal antibody assay and kit designed for detecting metallic cations in body fluids. This invention provides methods and kits that utilize at least two different types of antibodies with varying specificities. The preferred method involves contacting a sample of body fluid with a capture antibody specific for a naturally occurring polypeptide that binds the metallic cation, forming a first antigen-antibody complex. Subsequently, an effective amount of an antibody specific for either an epitope on the metallic cation-naturally occurring polypeptide complex or the metallic cation itself is added to create a second antigen-antibody complex. The amount of the metallic cation in the body fluid sample is then determined by detecting the second antigen-antibody complex.
Career Highlights
Malcolm Riddell is currently associated with Bionebraska, Inc., where he continues to innovate in the field of medical diagnostics. His work is characterized by a commitment to improving detection methods that can lead to better health outcomes.
Collaborations
Riddell has collaborated with notable colleagues, including Randall R Carlson and Jay S Stout, who contribute to the advancement of his research and inventions.
Conclusion
Malcolm Riddell's contributions to the field of monoclonal antibody assays exemplify the importance of innovation in medical diagnostics. His work not only enhances detection methods but also paves the way for future advancements in healthcare technology.